PASREL-Imagerie was created with the aim of opening the imaging research core facilities of the CEA-Jacob (MIRCen and IDMIT) and CEA-Joliot (NeuroSpin and SHFJ) institutes to pharmaceutical companies, in order to support, accelerate, and de-risk their diagnostic and therapeutic innovations. It provides cutting-edge expertise and translational imaging platforms, including PET, MRI, ultrasound, multimodal imaging, and radiopharmaceutical production.
Since receiving funding under the French State and Île-de-France Region SESAME FILIÈRE PIA program, four years have passed—four years dedicated to structuring the ecosystem, fostering the imaging community, and adopting a forward-looking approach to better understand industry expectations and develop targeted collaborations.
All these achievements are presented in PASREL-Imagerie’s first activity report, published on February 5.